The SA Journal Diabetes & Vascular Disease Volume 17 No 1 (July 2020)

29 / 42

SA JOURNAL OF DIABETES & VASCULAR DISEASE RESEARCH ARTICLE
VOLUME 17 NUMBER 1 • JULY 2020 27
We observed a lower level of physical activity among rural than
urban students. This finding was unexpected, most likely explained
by the fact that rural students were in a boarding school therefore
had minimal travelling distance to their classes.45
There are some limitations. The study had a small sample size
and relied on some self-reported variables that were prone to recall
bias. We measured blood pressure on only two visits. More than
two readings would have been needed to provide the best estimate
of blood pressure.
Conclusion
This study has shown that hypertension, overweight/obesity and
alcohol intake were common among these senior secondary school
students in Botswana. Strategies to prevent the risk factors of
CVD should be developed and implemented to avoid CVD-related
morbidity and mortality in the future. These strategies are being
advanced and will be the subject of future research.
This work was supported by the University of Botswana Office of
Research and Development (ORD) Post-graduate Internal Funding
(Round 6). The datasets used and/or analysed during the current
study are available from the corresponding author on reasonable
request.
References
1. Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, et al.
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J
Epidemiol 2011; 40(4): 885–901.
2. Muthuri SK, Francis CE, Wachira L-JM, LeBlanc AG, Sampson M, Onywera VO, et
al. Evidence of an overweight/obesity transition among school-aged children and
youth in sub-Saharan Africa: a systematic review. PLoS One 2014; 9(3): e92846.
3. World Health Organization. A global brief on hypertension: silent killer, global
public health crisis. World Health Organization [Internet]. 2015 19 April 2018.
Available from:
DCO_WHD_2013.2_eng.pdf?sequence=1.
4. Steyn NP, Mchiza ZJ. Obesity and the nutrition transition in sub-Saharan Africa.
Ann N York Acad Sci 2014; 1311(1): 88–101.
5. Urrutia-Rojas X, Egbuchunam CU, Bae S, Menchaca J, Bayona M, Rivers PA,
et al. High blood pressure in school children: prevalence and risk factors. BMC
Pediatrics 2006; 6(1): 32.
6. De Moraes ACF, Lacerda MB, Moreno LA, Horta BL, Carvalho HB. Prevalence
of high blood pressure in 122,053 adolescents: a systematic review and meta-
regression. Medicine 2014; 93(27): e232.
7. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood a
systematic review and meta–regression analysis. Circulation 2008; 117(25):
3171–3180.
8. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children
and adolescents. J Am Med Assoc 2007; 298(8): 874–879.
9. Moyer VA. Screening for primary hypertension in children and adolescents: US
Preventive Services Task Force Recommendation Statement. Ann Int Med 2013;
159(9): 613–619.
10. Monyeki KD, Kemper HCG. The risk factors for elevated blood pressure and how
to address cardiovascular risk factors: a review in paediatric populations. J Hum
Hypertens 2008; 22(7): 450–459.
11. Feber J, Ahmed M. Hypertension in children: new trends and challenges. Clin Sci
2010; 119(4): 151–161.
12. Lee WW. An overview of pediatric obesity. Pediat Diabetes 2007; 8(s9): 76–87.
13. Falkner B. Hypertension in children and adolescents: epidemiology and natural
history. Pediat Nephrol 2010; 25(7): 1219–1224.
14. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer
M, et al. Global, regional, and national comparative risk assessment of 79
behavioural, environmental and occupational, and metabolic risks or clusters of
risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of
Disease Study 2013. Lancet 2015; 386(10010): 2287–2323.
15. Imamura F, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, et al. Dietary
quality among men and women in 187 countries in 1990 and 2010: a systematic
assessment. Lancet Glob Health 2015; 3(3): e132– e142.
16. Sallis JF, Cerin E, Conway TL, Adams MA, Frank LD, Pratt M, et al. Physical activity
in relation to urban environments in 14 cities worldwide: a cross-sectional study.
Lancet 2016; 387(10034): 2207–2217.
17. Kandala N-B, Campbell EK, Rakgoasi SD, Madi-Segwagwe BC, Fako TT. The
geography of HIV/AIDS prevalence rates in Botswana. HIV/AIDS (Auckland, NZ)
2012; 4: 95.
18. World Health Organization. Millennium development goals. World Health
Organization [Internet]. 2008 19 April 2018. Available from:
iris/bitstream/handle/10665/205520/B3463. pdf?sequence=1&isAllowed=y.
19. Mwita JC, Magafu M, Omech B, Tsima B, Dewhurst MJ, Goepamang M, et al.
Undiagnosed and diagnosed diabetes mellitus among hospitalised acute heart
failure patients in Botswana. SAGE Open Med 2017; 5: 2050312117731473.
20. Dahm CC, Chomistek AK, Jakobsen MU, Mukamal KJ, Eliassen AH, Sesso HD,
et al. Adolescent diet quality and cardiovascular disease risk factors and incident
cardiovascular disease in middle- aged women. J Am Heart Assoc 2016; 5(12):
e003583.
21. Botswana Statistics. Botswana population and housing census 2011 19 April
2018; 211: 1– 4. Available from: . bw/sites/default/files/
publications/Population%20and%20Housing%20Census%202011%20%20
Dissemination%20seminar%20report.pdf.
22. World Health Organization. WHO AnthroPlus for personal computers Manual:
Software for assessing growth of the world’s children and adolescents. Geneva:
WHO [Internet]. 2009 19 April 2018. Available from:
growthref/tools/who_anthroplus_manual.pdf.
23. Onis Md, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development
of a WHO growth reference for school-aged children and adolescents. Bull Wld
Health Organ 2007; 85(9): 660–667.
24. Katzmarzyk P. Waist circumference percentiles for Canadian youth 11–18 y of age.
Eur J Clin Nutr 2004; 58(7): 1011–1015.
25. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J,
et al. 2014 Evidence-based guideline for the management of high blood pressure
in adults: report from the panel members appointed to the Eighth Joint National
Committee (JNC 8). J Am Med Assoc 2014; 311(5): 507–520.
26. National High Blood Pressure Education Program Working Group on High
Blood Pressure in Children and Adolescents. The fourth report on the diagnosis,
evaluation, and treatment of high blood pressure in children and adolescents.
Pediatrics 2004; 114(2): 555–576.
CARVETREND 6,25, 12,5, 25 mg. Each tablet contains 6,25, 12,5, 25 mg carvedilol respectively. S3
A37/7.1.3/0276, 0277, 0278. NAM NS2 08/7.1.3/0105, 0104, 0103. BOT S2 BOT1101790, 1791, 1792. For
full prescribing information, refer to the professional information approved by SAHPRA, December 2014.
1) Panagiotis C Stafylas, Pantelis A Sarafidis. Carvedilol in hypertension treatment. Vascular Health and Risk
Management 2008;4(1):23-30. CDE479/07/2018.
CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
C A R V E D I L O L 6,25 mg 12,5 mg 25 mg
CARVEDILOL:
• is indicated twice daily for
mild to moderate stable
symptomatic congestive
heart failure
• is indicated once daily for
essential mild to moderate
hypertension
• has a positive effect
on metabolic parameters.1
RESTORE
cardiac function
ß